DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Zileuton
Zileuton
Medication Coverage Policy
Clinical Guideline for the Diagnosis, Evaluation and Management of Adults and Children with Asthma
Montreal Protocol on Substances That Deplete the Ozone Layer
Comparison of Effect of Leukotriene Biosynthesis Blockers and Inhibitors of Phosphodiesterase Enzyme in Patients with Bronchial Hyperreactivity
FDA Briefing Document Pulmonary-Allergy Drugs Advisory Committee Meeting
Intracolonic Administration of Zileuton, a Selective 5-Lipoxygenase Inhibitor, Accelerates Healing in a Rat Model of Chronic Colitis
Monteleucast and Zileuton Retard the Progression of Atherosclerosis Via Down Regulation of the Inflammatory and Oxidative Pathwa
Leukotriene Modifiers (Accolate®, Singulair®, Zileuton®)
Zileuton for the Prophylaxis and Chronic Treatment of Asthma
Pharmacology and Therapeutics of Bronchodilators
COPD/Asthma Class Update
Antileukotriene Agents in Asthma: the Dart That Kills the Elephant?
Pranlukast, a Novel Leukotriene Receptor Antagonist 525
Zileuton Extended-Release (Generic Zyflo
ZYFLO® (Zileuton Tablets)
5-Lipoxygenase: Emerging Therapeutic Targets in Central Nervous System Disorders
Leukotriene Inhibitors in the Treatment of Allergy and Asthma DEAN THOMAS SCOW, M.D., St
Therapeutic Class Overview Leukotriene Modifiers
Top View
PRODUCT INFORMATION Asthma Treatment Standard Set Item No
Preventive Medications List
Inhibition of 5-Lipoxygenase Product Synthesis by Natural Compounds Of
Pharmacological Treatment Options and Tier Coverage for Copd/Asthma
Envolve Pharmacy Solutions Criteria Working Template ACCESSIBLE
Genome-Wide Association Study of Leukotriene Modifier Response In
Role of Leukotriene Modifiers in the Treatment of Asthma 7
A Randomized Controlled Trial Comparing Zileuton with Theophylline in Moderate Asthma
AC18 COPD Handout.Pdf
Overview of the Pharmacogenetics of Asthma Treatment
Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: the Leukotriene (LT)B4-VEGF Axis
Drug Development for Asthma and COPD: a Regulatory Perspective
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Clinical Review Tiotropium Clinical Review
Long-Acting Asthma and COPD Drugs Drug Effectiveness Review Project Summary Report
The Effect of Inhaled Corticosteroids on Survival in a COPD Cohort
Marine Drugs
Preferred Drug List (PDL)
Leukotriene Modifiers
Leukotriene Modifiers, Cromolyn, Theophylline: Search Strategies
Customs Tariff - Schedule Xxi - 1
Antileukotrienes and Asthma: Alternative Or Adjunct to Inhaled Steroids?
The Role of Leukotrienes As Potential Therapeutic Targets in Allergic Disorders
Pharmacological Treatment Options and Tier Coverage for Copd/Asthma
Nuclear Translocation of Cysteinyl Leukotriene Receptor 1 Is Involved in Oxygen-Glucose Deprivation- Induced Damage to Endothelial Cells
Medication Regimens for Managing Stable Asthma
Spontaneous Nasal Polypectomy Proceeded by Fluticasone Propionate (XHANCE®) and Zileuton (Xyflo®) Application
Learn More About Usual Doses for Long Term Controller Medications
Medication Coverage Policy
Effect Ofa 5-Lipoxygenase Inhibitor on Leukotriene Generation and Airway Responses After Allergen Challenge in Asthmatic Patients 189
Non-Preferred Drug List (NPDL)
Pharmacological Treatment of Asthma Today
Trelegy Ellipta, INN-Fluticasone Furoate / Umeclidinium / Vilanterol
Lipoxygenase Inhibitors As Potential Cancer Chemopreventives
Bronchodilators, Long-Acting Beta-Agonists Therapeutic Class Review
2020 Essential Asthma Drug List
(12) United States Patent (10) Patent No.: US 8,268,861 B2 Boes (45) Date of Patent: Sep
FDA Briefing Document
ZYFLO CR (Zileuton) Extended-Release Tablets Periodically Thereafter
Safety and Efficacy of Tiotropium Bromide in Copd Patients
Beta Agonists: Inhaled, Single Entity Agents, Long Acting